Tetsuro Otsuka

Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study

Tadao Akizawa, Tetsuro Otsuka, Michael Reusch et al. · Therapeutic Apheresis and Dialysis · 2019 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka et al. · Advances in Therapy · 2019 · 84 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka et al. · Kidney International Reports · 2021 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Tadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka et al. · ˜The œNephron journals/Nephron journals · 2020 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients

Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka et al. · American Journal of Nephrology · 2021 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16